Abstract Background Malaria caused by Plasmodium vivax is an experimentally neglected severe disease with a substantial burden on human health. Because of technical limitations, little is known about the biology of this important human pathogen. Whole genome analysis methods on patient-derived material are thus likely to have a substantial impact on our understanding of P. vivax pathogenesis and epidemiology. For example, it will allow study of the evolution and population biology of the parasite, allow parasite transmission patterns to be characterized, and may facilitate the identification of new drug resistance genes. Because parasitemias are typically low and the parasite cannot be readily cultured, on-site leukocyte depletion of blood ...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
International audienceBACKGROUND: An estimated 2.85 billion people live at risk of Plasmodium vivax ...
Abstract Background Malaria caused by Plasmodium viva...
Plasmodium vivax causes 25-40% of malaria cases worldwide, yet research on this human malaria parasi...
ABSTRACT Whole-genome sequencing (WGS) of microbial pathogens from clinical samples is a highly sens...
Whole-genome sequencing (WGS) of microbial pathogens from clinical samples is a highly sensitive too...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
<div><p>Whole genome sequencing (WGS) of <em>Plasmodium vivax</em> is problematic due to the relianc...
Background Translating genomic technologies into healthcare applications for the malaria parasite Pl...
Abstract Background Plasmodium vivax poses a significant challenge to malaria elimination due to its...
The genomic diversity of Plasmodium malariae malaria parasites is understudied, partly because infec...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
International audienceBACKGROUND: An estimated 2.85 billion people live at risk of Plasmodium vivax ...
Abstract Background Malaria caused by Plasmodium viva...
Plasmodium vivax causes 25-40% of malaria cases worldwide, yet research on this human malaria parasi...
ABSTRACT Whole-genome sequencing (WGS) of microbial pathogens from clinical samples is a highly sens...
Whole-genome sequencing (WGS) of microbial pathogens from clinical samples is a highly sensitive too...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
<div><p>Whole genome sequencing (WGS) of <em>Plasmodium vivax</em> is problematic due to the relianc...
Background Translating genomic technologies into healthcare applications for the malaria parasite Pl...
Abstract Background Plasmodium vivax poses a significant challenge to malaria elimination due to its...
The genomic diversity of Plasmodium malariae malaria parasites is understudied, partly because infec...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
Whole genome sequencing (WGS) of Plasmodium vivax is problematic due to the reliance on clinical iso...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of...
International audienceBACKGROUND: An estimated 2.85 billion people live at risk of Plasmodium vivax ...